# Paper Redteam Report: Synthetic Example

## Metadata

- Target venue: ICLR 2026
- Paper type: method paper
- Draft scope reviewed: title, abstract, introduction plan, contribution list, synthetic results summary
- Sources checked: toy paper context, claim-evidence matrix, cspapers hit classification

## Desk-Reject Risks

- No immediate formatting desk-reject risk shown in the provided context.
- Anonymous review status still needs final PDF/source metadata check.

## R1: Technical Correctness

Strengths:

- The paper has a clear mechanism: sampling multiple masks to represent ambiguity.
- The synthetic setup makes uncertainty controllable.

Major concerns:

- The method needs a precise definition of "plausible mask."
- The connection between diffusion sampling and calibration needs clearer explanation.

Required fixes:

- Add a formal description of the mask distribution and sampling process.
- Define calibration target and uncertainty metric before reporting results.

## R2: Novelty And Related Work

Strengths:

- The intended contribution is clear after narrowing to synthetic annotator disagreement.

Major concerns:

- Draft novelty language is too strong.
- cspapers-style search indicates likely overlap with diffusion segmentation work.

Required fixes:

- Remove "first" claim.
- Inspect and cite direct overlap papers.
- Explain how the synthetic calibration setup differs from prior diffusion segmentation work.

## R3: Experiments And Evidence

Strengths:

- Baseline set includes deterministic and ensemble models.
- Metrics include both overlap and calibration.

Major concerns:

- Results are synthetic placeholder numbers; this must be explicit.
- No external or real clinical validation exists.

Required fixes:

- Avoid clinical utility claims.
- Add ablations for sampling steps and uncertainty loss.
- Report variance across random seeds.

## R4: Presentation

Strengths:

- The thesis can be explained in one sentence.

Major concerns:

- The abstract should state "synthetic" early.
- The introduction should not start with broad medical AI claims.

Required fixes:

- Start with annotator disagreement in segmentation.
- State the synthetic scope in the first paragraph.

## AC Meta Review

Decision-critical issues:

- Novelty must be narrowed and supported by related-work inspection.
- Claims must be scoped to synthetic data.
- Method and calibration definitions must be precise.

Highest-impact fixes:

1. Rewrite abstract and introduction with synthetic scope.
2. Complete related-work inspection for diffusion segmentation.
3. Add calibration metric definitions and ablations.

Residual risk:

- Without real medical data, the paper should be framed as a methodological or controlled synthetic study, not a clinical imaging paper.
